[go: up one dir, main page]

IL65448A - Procedure for producing a vasal fibrinolytic active principle and the enzymatic product so prepared - Google Patents

Procedure for producing a vasal fibrinolytic active principle and the enzymatic product so prepared

Info

Publication number
IL65448A
IL65448A IL65448A IL6544882A IL65448A IL 65448 A IL65448 A IL 65448A IL 65448 A IL65448 A IL 65448A IL 6544882 A IL6544882 A IL 6544882A IL 65448 A IL65448 A IL 65448A
Authority
IL
Israel
Prior art keywords
active principle
procedure
prepared
producing
enzymatic product
Prior art date
Application number
IL65448A
Other languages
English (en)
Other versions
IL65448A0 (en
Original Assignee
Manetti & Roberts Italo Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manetti & Roberts Italo Brit filed Critical Manetti & Roberts Italo Brit
Publication of IL65448A0 publication Critical patent/IL65448A0/xx
Publication of IL65448A publication Critical patent/IL65448A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL65448A 1981-04-23 1982-04-06 Procedure for producing a vasal fibrinolytic active principle and the enzymatic product so prepared IL65448A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48332/81A IT1170913B (it) 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche

Publications (2)

Publication Number Publication Date
IL65448A0 IL65448A0 (en) 1982-07-30
IL65448A true IL65448A (en) 1985-07-31

Family

ID=11265948

Family Applications (1)

Application Number Title Priority Date Filing Date
IL65448A IL65448A (en) 1981-04-23 1982-04-06 Procedure for producing a vasal fibrinolytic active principle and the enzymatic product so prepared

Country Status (16)

Country Link
US (2) US4471053A (xx)
EP (1) EP0064036B1 (xx)
JP (1) JPS57181019A (xx)
AT (1) ATE15071T1 (xx)
AU (1) AU548758B2 (xx)
CA (1) CA1184138A (xx)
DE (1) DE3265559D1 (xx)
DK (1) DK180682A (xx)
ES (1) ES8501797A1 (xx)
IE (1) IE53107B1 (xx)
IL (1) IL65448A (xx)
IT (1) IT1170913B (xx)
NO (1) NO821287L (xx)
NZ (1) NZ200254A (xx)
PT (1) PT74743B (xx)
ZA (1) ZA822703B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
JPS58189122A (ja) * 1982-04-30 1983-11-04 Kaken Pharmaceut Co Ltd 高脂血症予防治療剤
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
HU209955B (en) * 1987-07-01 1994-12-28 Genentech Inc Process for producing pharmaceutical compositions containing tissue- -plasminogen-activator of poor solubility for inhibiting production and regeneration of deformities
US5215908A (en) * 1989-06-13 1993-06-01 Genencor International, Inc. Process for recovery and purification of chymosin
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
MXPA00000009A (es) 1998-06-22 2005-09-08 Autologous Wound Therapy Inc Solicitud para patente de utilidad para curativo de heridas mejorado enriquecido con plaquetas.
WO2006102488A1 (en) * 2005-03-22 2006-09-28 Cascade Medical Enterprises, Llc Systems and methods of producing membranes
DE102015010436B4 (de) * 2015-08-14 2019-01-24 Airbus Defence and Space GmbH Wabenkern für dimensionsstabile Sandwichbauteile, dessen Verwendung, Sandwichplatte mit diesem Wabenkern und Verfahren zur Herstellung des Wabenkerns

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998847A (en) * 1972-10-25 1976-12-21 Schering Aktiengesellschaft 9,10-secoestrane derivatives and their production
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
US4381346A (en) * 1979-11-13 1983-04-26 Huasin Syed S Isolation of plasminogen activators useful as therapeutic and diagnostic agents
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent

Also Published As

Publication number Publication date
AU8237582A (en) 1982-10-28
US4532129A (en) 1985-07-30
CA1184138A (en) 1985-03-19
ES511604A0 (es) 1984-12-01
EP0064036B1 (en) 1985-08-21
DE3265559D1 (en) 1985-09-26
JPS57181019A (en) 1982-11-08
IL65448A0 (en) 1982-07-30
IT1170913B (it) 1987-06-03
AU548758B2 (en) 1986-01-02
IE820952L (en) 1982-10-23
ES8501797A1 (es) 1984-12-01
EP0064036A1 (en) 1982-11-03
PT74743B (en) 1983-11-09
IE53107B1 (en) 1988-06-22
IT8148332A0 (it) 1981-04-23
DK180682A (da) 1982-10-24
ZA822703B (en) 1983-03-30
NZ200254A (en) 1985-07-12
PT74743A (en) 1982-05-01
US4471053A (en) 1984-09-11
NO821287L (no) 1982-10-25
ATE15071T1 (de) 1985-09-15

Similar Documents

Publication Publication Date Title
DE3265559D1 (en) Procedure for producing a vasal fibrinolytic active principle and the enzymatic product so prepared
AU576365B2 (en) Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
ES2007341A6 (es) Un procedimiento para producir m-csf
ES488120A1 (es) Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos
DK235584D0 (da) Fremgangsmaade til fremstilling af et valleprodukt
HUT42955A (en) Process for production of plasminogene activator compositions of stabilized human-tissue
ES2063194T3 (es) Procedimiento de produccion de acido fosfatidico.
HUT40804A (en) Process for production of medical preparatives containing n-acetyl neuramin acid
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
ZA823248B (en) New anti-thromboticum based on polysacharides,method for its preparation and pharmaceutical compositions
SE7602751L (sv) Framstellning av n-acyl-l-metionin
AU524777B2 (en) Isolation of tissue protein ppg.
UY25097A1 (es) Proceso para la produccion de heparina
AU570574B2 (en) Depolymerase enzymes and treatment of fireblight
AU6932691A (en) Administration method of antithrombin
ES2176349T3 (es) Proceso de sililacion.
ES2059568T3 (es) Procedimiento para la elaboracion de una enzima de aspergillus macerante.
ES8702304A1 (es) Procedimiento para fabricar carbonato de sodio anhidro denso
EP0231425A3 (en) Use of a solution of alpha-chymotrypsin
SU1197669A1 (ru) Способ лечени нагноительных заболеваний легких
ES551375A1 (es) Procedimiento de obtencion de un producto comprimido para aplicacion oftalmologica local.
EP0351809A3 (en) Blood anticoagulant
EP0261088A3 (en) Process for the production of heparanlysopeptide sulphate, the product thus obtained and its therapeutic use
HUT34950A (en) Process for the production of alpha-allene-alpha-amino acids and of therapeutic preparations containing such agents
UA15579A (uk) Раhозагоювальhий засіб